CHICAGO — New research is showing certain weight loss drugs could be linked to eye related issues.
A couple studies published in the Journal of the American Medical Association looks into Ozempic, Wegovy, Mounjaro, and Zepbound and the impact they have been having on eye health in Americans with type 2 diabetes.
One study shows there’s modest risk in developing an eye condition that could result in vision loss.
Another study showed an increased risk of other eye issues.








